BN
Bruce N. Jacobs
DELAYED 1 MONTH
Chief Financial Officer
Kymera Therapeutics, Inc.
Filings
3
Companies
1
Latest
Jun 2, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Kymera Therapeutics, Inc.
Bruce N. Jacobs
Chief Financial Officer
Option Exercise
$26.3K
12,653 sh
Jun 3 11:30 AM
Jun 2, 2026
—
Kymera Therapeutics, Inc.
Bruce N. Jacobs
Chief Financial Officer
Option Exercise
$31.2K
15,000 sh
May 19 11:30 AM
May 18, 2026
65
KYMRCLUSTER 2
Kymera Therapeutics, Inc.
Bruce N. Jacobs
Chief Financial Officer
Sale
$417.5K
4,895 sh
Mar 4 11:00 PM
Mar 4, 2026
65
KYMRCLUSTER 2
Kymera Therapeutics, Inc.
Bruce N. Jacobs
Chief Financial Officer
Sale
$673.7K
7,576 sh
Mar 4 11:00 PM
Mar 2, 2026